Position in TMO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,355,389
+$17,673 QoQ
Shares Held
4,698
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1,111
of 2,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Convergence Financial, LLC holds $3,110,070 across 2 Diagnostics & Research names. TMO ranks #1 (75.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
4,698 | $2,355,389 | |
| 2 | DHR |
Danaher Corp /De/
|
3,962 | $754,681 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,355,389 | 4,698 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,337,716 | 4,756 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,398,212 | 2,413 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,127,186 | 2,324 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $952,425 | 2,349 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,624,166 | 3,264 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,584,100 | 3,045 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,819,832 | 2,942 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,244,250 | 2,250 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||